NeoGraph Analytics
Medical ImagingNorth America2023 – 2032

Global Europe Medical Imaging AI Market Analysis, Opportunities and Forecast 2024-2032

Europe Medical Imaging AI market valued at USD 0.95B in 2023, projected to reach USD 7.05B by 2032 at a 26.5% CAGR, driven by rising imaging volumes.

Revenue, 2023

$0.9B

Forecast, 2032

$7.9B

CAGR, 2024-2032

26.5%

Report Coverage

North America

Code: europe-medical-imaging-ai-marketPublished: 2026Pages: 150+Format: PDF + Excel
01

Executive Summary

The Europe Medical Imaging AI market, valued at USD 0.95 billion in 2023, is projected to reach USD 7.05 billion by 2032, growing at a CAGR of 26.5%. Key growth drivers include rising radiologist shortages, increasing imaging volumes, EU regulatory frameworks supporting AI adoption, and major investments by Siemens Healthineers, Philips, and emerging AI-native firms. Radiology and cardiology applications dominate current adoption, while oncology and neurology represent high-growth frontiers. Germany, the United Kingdom, and France lead regional adoption, supported by robust digital health infrastructure. Challenges include data privacy compliance under GDPR, interoperability barriers, and clinician trust gaps. The market presents significant investment opportunities in AI-powered diagnostic platforms, cloud-based imaging solutions, and point-of-care AI tools across European healthcare systems.

02

Key Highlights

1

Market valued at USD 0.9B in 2023, growing at 26.5% CAGR

2

North America leads with largest regional market share

3

Asia Pacific is the fastest-growing regional market

03

Market Overview

Market Context

The Medical Imaging AI market is shaped by rapid technological innovation, shifting consumer preferences, and increasing regulatory focus on sustainability and compliance.

Europe accounts for approximately 28% of the global medical imaging AI market, with rapid adoption driven by aging populations, rising chronic disease burden, and strong government-backed digital health strategies. The EU AI Act and MDR framework provide structured regulatory pathways for AI-based medical devices. Germany, the UK, France, and the Nordics lead clinical integration of AI into radiology, cardiology, and pathology workflows.

Market Stage

High growth

Adoption Level

Growing

Key Trends

Growing adoption of cloud-based AI imaging platforms across European hospital networksEU AI Act establishing risk-based classification for AI medical devicesRise of AI-native startups challenging incumbent OEMs in diagnostic imagingIntegration of generative AI for automated radiology reporting and clinical decision support
04

Market Forecast & Data

Market Growth Forecast
2024-2032 · CAGR 26.5%

Base Year (2023)

$0.9B

Forecast (2032)

$7.9B

CAGR (2024-2032)

26.5%

Market size by year, 2024-2032, in USD Billion.
YearMarket size ($ Billion)
2023Base year$0.95B
2024$1.20B
2025$1.52B
2026$1.92B
2027$2.43B
2028$3.08B
2029$3.89B
2030$4.92B
2031$6.23B
2032$7.88B
Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
Forecast Analysis

The market is forecast to maintain robust growth through 2032, driven by expanding applications, new entrant investments, and emerging market adoption.

Regional Market Analysis
Market share and growth rate by region
Regional market analysis — market share, growth rate and largest market by region.
RegionMarket shareGrowth rateLargest market
North America38.0%26.5%United States
Europe28.0%23.9%Germany
Asia Pacific26.0%29.2%China
Rest of World8.0%21.2%Brazil

North America

#1
Share: 38.0%CAGR: 26.5%

Largest market: United States

Europe

#2
Share: 28.0%CAGR: 23.9%

Largest market: Germany

Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
05

Market Dynamics

  • Rising radiologist shortages and increasing diagnostic imaging volumes across Europe
  • EU regulatory frameworks supporting AI-enabled medical device approvals
  • Growing investments in digital health infrastructure and AI R&D
06

Market Segmentation

By Type
Market share distribution across 2 segments
By Type — market share by segment, in percent.
SegmentShare
Type ADominant Medical Imaging AI segment.55.0%
Type BGrowing Medical Imaging AI segment.45.0%
Total100.0%
Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.

By End User

  • Enterprise
  • SMB
  • Government
07

Regional Analysis

1

North America

Lead: United States
CAGR: 26.5%Share: 38.0%

Largest market driven by technology adoption and R&D investment.

2

Europe

Lead: Germany
CAGR: 23.9%Share: 28.0%

Strong regulatory framework supports market growth.

3

Asia Pacific

Lead: China
CAGR: 29.2%Share: 26.0%

Fastest growing region driven by rapid industrialization.

4

Rest of World

Lead: Brazil
CAGR: 21.2%Share: 8.0%

Emerging markets present untapped growth opportunities.

Country-Level Analysis

Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
Market share and growth rate by country
CountryShareGrowth
United States
28.0%
+25.2%
China
18.0%
+31.8%
Germany
9.0%
+22.5%
Japan
7.0%
+21.2%
United Kingdom
6.0%
+23.3%
08

Competitive Landscape

S

Siemens Healthineers

Germany

LeaderN/A

Dominant player with comprehensive AI-powered imaging portfolio including AI-Rad Companion, integrated across CT, MRI, and molecular imaging platforms.

P

Philips Healthcare

Netherlands

ChallengerN/A

Strong presence in AI-enabled CT and MRI solutions, advancing precision diagnosis with integrated informatics and AI-driven clinical decision support.

A

Aidoc

Israel

FollowerN/A

AI-native company specializing in acute care imaging AI for radiology workflow triage, with growing European hospital deployments.

09

Recent Developments

25
2025Siemens Healthineers

Launched next-generation Medical Imaging AI platform with enhanced AI-driven capabilities.

25
2025Philips Healthcare

Expanded market presence through strategic partnership in Asia Pacific region.

24
2024Siemens Healthineers

Reported record annual revenue growth driven by strong Medical Imaging AI product demand.

10

Regulatory Landscape

Compliance with regional data protection and privacy regulationsIndustry-specific quality and safety standards
11

Research Methodology

Primary research

  • Expert interviews
  • Industry surveys

Secondary research

  • Industry reports
  • Company financials
  • Government databases

Validation: Triangulation method with cross-referencing multiple data sources

12

Strategic Takeaways

Investors

High-growth Medical Imaging AI sector offers compelling entry opportunities

Operators

Focus on technology differentiation to capture market share

13

Frequently Asked Questions

Reports in the same field, each with its base-year figure and the growth rate it is published at.